GIST, Malignant
7
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
28.6%
2 terminated out of 7 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
GIST and Memory and Attention Adaptation Training
French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Nutrition in Gastrointestinal Tumors
Liver Transplantation for Unresectable GIST Liver Metastases
POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST